Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee.

Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee.
复制标题

氨基葡萄糖治疗膝骨关节炎的随机对照试验。

DOI:
--
复制
发表时间:
2000
期刊:
Western Journal of Medicine
影响因子:
--
通讯作者:
Greg Arriola
Greg Arriola
中科院分区:
--
文献类型:
--
作者:
J. Rindone;D. Hiller;E. A. Collacott;N. Nordhaugen;Greg Arriola

文献摘要

参考文献

被引文献

相似文献

目的 确定氨基葡萄糖在减轻膝关节骨关节炎疼痛方面的有效性。 设计 氨基葡萄糖500 mg每日3次或安慰剂治疗2个月的随机、双盲平行试验。 设置 退伍军人事务医疗中心,普雷斯科特,亚利桑那州。 参与者 98名年龄在34 - 81岁的患者接受膝关节骨关节炎治疗。 主要观察指标 在基线和治疗30天和60天后,通过视觉模拟量表评估静息和行走时的疼痛强度。 结果 49名患者被随机分配到每组。两组在休息30天时的视觉模拟量表评分无统计学差异(安慰剂组平均[SD]评分3.5 [2.7] vs葡萄糖胺组3.3 [2.4],P = 0.66)或步行(5.1 [2.6] vs 5.3 [2.4],P = 0.69);在60天时,休息(3.4 [2.5] vs 3.2 [2.5],P = 0.81)或行走(4.9 [2.2] vs 4.9 [2.8],P = 0.90)也没有差异。两组之间视觉模拟量表评分较基线的平均变化也无统计学差异(安慰剂组60天时行走的平均[SD]变化-1.5 [2.5] vs葡萄糖胺组-1.4 [3.0],P = 0.77)。两名服用葡萄糖胺的参与者和4名服用安慰剂的参与者由于不良副作用而退出研究(P = 0.67)。 结论 在这组患者中,氨基葡萄糖在减轻膝关节骨关节炎疼痛方面并不比安慰剂好。
OBJECTIVE To determine the effectiveness of glucosamine in reducing pain from osteoarthritis of the knee. DESIGN Randomized, double-blind parallel trial of glucosamine 500 mg three times daily or a placebo for 2 months. SETTING Veterans Affairs Medical Center, Prescott, AZ. PARTICIPANTS Ninety-eight patients aged 34 to 81 being treated for osteoarthritis of the knee. MAIN OUTCOME MEASURES Pain intensity both at rest and while walking as assessed by a visual analog scale at baseline and after 30 and 60 days of treatment. RESULTS Forty-nine patients were randomly allocated to each group. There was no statistical difference between the two groups in scores on the visual analog scale at 30 days for resting (mean [SD] score placebo group 3.5 [2.7] vs 3.3 [2.4] glucosamine group, P = 0.66) or walking (5.1 [2.6] vs 5.3 [2.4], P = 0.69); there was also no difference at 60 days for resting (3.4 [2.5] vs 3.2 [2.5], P = 0.81) or walking (4.9 [2.2] vs 4.9 [2.8], P = 0.90). There was also no statistical difference between groups in the mean change from baseline in scores on the visual analog scale (mean [SD] change for walking at 60 days placebo group -1.5 [2.5] vs glucosamine group -1.4 [3.0], P = 0.77). Two participants taking glucosamine and 4 taking placebo withdrew from the study due to adverse side effects (P = 0.67). CONCLUSION Glucosamine was no better than placebo in reducing pain from osteoarthritis of the knee in this group of patients.
DOI: 10.1016/s1063-4584(98)80011-3
发表时间: 1998-05-01
影响因子: 7
作者:
Uebelhart, D;Thonar, EJMA;Vignon, E
通讯作者: Vignon, E